Medicament for influencing the degree of activation of the central nervous system

US5591732A · kind A · utility

Inventors

• Claudia Mattern · Starnberg, DE
• Rudiger Hacker · Herrsching am Ammersee, DE

Key dates

• Filing date: Jun 17, 1994
• Grant date: Jan 7, 1997
• Expiry date: Jun 17, 2014

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of a medicament with a content of metanolone and/or Oral Turinabol for increasing and optimizing the degree of activation of the central nervous system and/or for prophylaxis and therapy of osteoporosis.